Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on Risk Stratification of Overlap Syndrome Phenotype (Brugada and Long QT Type 3) in Patients With E1784K Mutation in SCN5A

NCT05274646 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Réunion as lead sponsor.

NCT NCT05274646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on Risk Stratification of Overlap Syndrome Phenotype (Brugada and Long QT Type 3) in Patients With E1784K Mutation in SCN5A
Lead sponsor
Centre Hospitalier Universitaire de la Réunion
Phase
Observational
Overall status
Completed
Start date
April 5, 2022
Completion date
March 20, 2024
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, brugada syndrome, cardiac conduction system disease, long qt syndrome